FT Health Discusses Global Impacts Of Dementia, Features Interview With Takeda CEO Christophe Weber

FT Health: The need for fresh approaches on dementia
The latest issue of the Financial Times’ weekly global health newsletter highlights the global costs of dementia, the WHO’s new Global Dementia Observatory, and the Financial Times’ seasonal appeal for Alzheimer’s research. The newsletter also features an interview with Christophe Weber, chief executive of Japanese pharmaceutical company Takeda, and a roundup of other global health-related news stories (Jack/Dodd, 12/8).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.